首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 140 毫秒
1.
猪流感(H3N2亚型)油乳剂灭活疫苗的免疫及攻毒试验   总被引:1,自引:0,他引:1  
用不同剂量的猪流感H3N2亚型油乳剂灭活疫苗免疫15头断奶仔猪,每组5头,四周后二免。另外3头为非免疫攻毒对照组。首免后第10周用同源病毒攻毒,分别在免疫前及免疫后2、3、4、6、8、10、11周采血,分离血清,用HI试验检测其抗体滴度。攻毒后通过免疫猪和非免疫攻毒对照猪临床、病理变化及病毒分离等方面的比较,评价疫苗的保护效果。结果中、高剂量组的抗体滴度明显高于低剂量组;免疫组和对照组攻毒前后体温无显著差异(P>0.05),免疫组病理保护明显好于非免疫攻毒对照组;鼻液和肺中的病毒分离率比较,免疫组明显低于非免疫攻毒对照组。本研究表明,用该疫苗免疫后猪对同亚型的病毒攻击有一定的保护作用。  相似文献   

2.
为了研究伪狂犬病毒在猪体不同组织部位的分布和对外排毒规律,将14头50日龄仔猪随机分为实验组(10头)和对照组(4头)。实验组肌内注射半数致死为10~(6.5) TCID_(50)/mL PRV 2 mL,记录不同时间猪只的临床症状,并采用RT-PCR法对攻毒后不同时期各组织器官及血液、鼻拭子、肛门拭子的病毒载量进行研究。结果显示,PRV感染后12 h,试验猪只表现为体温升高、食欲不振、精神萎靡、咳嗽、打喷嚏等症状,攻毒后第3天逐渐出现神经症状;PCR检测表明PRV在体内分布较广,以淋巴结、肺脏、脑组织中病毒载量最高;攻毒不同时期病毒载量的变化规律为先上升后下降的趋势,以第7天或第14天病毒载量最高;对外排毒由高到低依次为鼻拭子、血液、肛门拭子,排毒时间持续35 d。通过研究PRV的分布规律和对外排毒规律,对于揭示PR的发病机制具有重要意义。  相似文献   

3.
本试验使用3~6月龄健康易感牛9头(牛传染性鼻气管炎病毒(IBRV)和牛病毒性腹泻病毒(BVDV)抗原、抗体均阴性),共分3组,每组3头犊牛。第1组首免肌肉注射IBRV-LNM弱毒疫苗株种毒,接种1周后,每头牛接种BVDV-SM弱毒疫苗株;第2组只接种BVDV-SM弱毒疫苗株种毒,接种时间同第1组;第3组为对照组,接种MDBK细胞培养液。接种BVDV-SM疫苗毒后每周采血至疫苗毒接种后28 d,测定接种后BVDV抗体效价,并采用BVDV-JL检验用强毒进行攻毒试验。结果表明,第1组与第2组试验动物血清中牛病毒性腹泻病毒抗体水平无明显差异,能够抵抗BVDV-JL强毒攻击达到免疫保护的效果,说明牛传染性鼻气管炎病毒IBRV-LNM弱毒疫苗株接种后在牛体内对牛病毒性腹泻病毒BVDV-SM疫苗毒不产生免疫干扰作用。  相似文献   

4.
将表达鸡传染性支气管炎病毒(IBV)S1基因的重组鸡痘病毒(rFPV-IBVS1)以5×106PFU剂量翅皮下注射接种4周龄的SPF鸡。血清抗体检测表明,该重组鸡痘病毒能刺激鸡体产生特异性抗体,外周血液中CD4 、TCRγδ T淋巴细胞比例显著高于对照组,而CD8 T淋巴细胞比例低于对照组。免疫后4周用1×103.0EID50的传染性支气管炎病毒LX4株进行攻毒,结果表明,重组鸡痘病毒免疫组与IB弱毒疫苗免疫保护率分别为12/16和13/16;攻毒后喉拭子IBV分离结果表明,IB弱毒疫苗和重组鸡痘病毒免疫组的IBV气管排毒时间比对照组缩短了2 d,病毒的分离率显著低于对照组;肾脏、气管、肺脏、腺胃、脾和肝脏的病理损伤也较对照组轻,而且病变持续时间缩短。  相似文献   

5.
将禽流感病毒血凝素 H9A基因克隆入插入载体 p FG11S中 ,通过酶切鉴定获得了正向转移载体 p FG11SHA;将其与禽痘病毒疫苗株 (w FPV)共转染鸡成纤维细胞 (CEF) ,通过蓝白斑筛选纯化得到重组病毒 r FPV- Ps- HA;以间接免疫荧光法证实 HA基因得到了表达。将该病毒经颈部皮下免疫 1日龄 SPF鸡 ,免疫后 15 d以 H9亚型禽流感病毒 F株翅静脉攻毒 ,攻毒后第 5天采集泄殖腔棉拭子样品进行病毒分离。将此重组病毒与以痘苗病毒 P7.5启动子表达相同基因的重组病毒 r FPV- P7.5 - HA作比较 ,结果表明 ,r FPV- Ps- HA相对于 r FPV- P7.5 - HA明显抑制了病毒的排出 ;攻毒后第 2、5、7、9、11天分别对 r FPV- Ps- HA、油乳剂灭活苗免疫鸡进行泄殖腔、气管排毒规律的检测 ,发现疫苗组均能很好地抑制排毒 ,攻毒对照组泄殖腔的排毒率明显高于气管排毒率  相似文献   

6.
为研究牛病毒性腹泻/黏膜病、传染性鼻气管炎二联灭活疫苗接种不同月龄肉犊牛后的免疫效果,对2月龄、3月龄犊牛进行牛病毒性腹泻/黏膜病、传染性鼻气管炎二联灭活疫苗疫接种实验,监测免疫抗体消长情况。实验结果显示:2月龄犊牛首次免疫后第20天时,牛传染性鼻气管炎(infectious bovine rhinotracheitis virus, IBRV)和牛病毒性腹泻病毒(bovine viral diarrhea virus, BVDV)中和抗体可达较高水平(平均抗体滴度分别达5.80和9.37);二免后第30天时中和抗体达到峰值(平均抗体滴度分别达8.20和11.50);3月龄犊牛首次免疫后第20天时,IBRV和BVDV中和抗体水平均较高(平均抗体滴度分别达5.91和6.80),二免后第30天时平均中和抗体滴度达到最高值(平均抗体滴度分别达7.20和11.80);随时间推移抗体滴度逐步下降,到二免后第210天时,80%牛只的IBRV中和抗体滴度不低于5.5,所有牛只的BVDV中和抗体滴度不低于7.0。实验结果表明:该疫苗两次免疫后肉牛体内BVDV、IBRV中和抗体免疫保护期可达210 d以...  相似文献   

7.
《中国兽医学报》2020,(2):264-271
前期研究发现高表达miR-29b能显著抑制牛病毒性腹泻病毒(bovine viral diarrhea virus,BVDV)在体外的复制,而miR-29b过表达是否影响BVDV在体内的复制尚未见有报道。研究设计扩增牛pre-miR-29b基因片段的引物,以MDBK基因组为模板,PCR扩增pre-miR-29b并克隆至慢病毒载体pLL3.7。将阳性质粒pLL3.7-pre-miR-29b与包装质粒共转染HEK-293T细胞,包装慢病毒并测定慢病毒滴度,同时包装pLL3.7空质粒的慢病毒作为阴性对照。将4~5周龄BALB/c小鼠随机分成5组,每组6只,连续2次尾静脉注射2.5×10~7 IU慢病毒悬液pLL3.7-pre-miR-29b或pLL3.7,并于慢病毒注射后96 h通过滴鼻途径攻毒BVDV毒株NADL(1.68×10~5 TICD_(50)/只),于攻毒后不同时间(0,2,4,10,15 d)处死BALB/c小鼠,采集心脏、肝脏、脾脏、肺脏、小肠和血液,提取总RNA,使用荧光定量RT-PCR检测不同组织中BVDV拷贝数;同时制备病理组织切片观察各组织病变情况。结果显示,成功构建pLL3.7-pre-miR-29b质粒;成功包装pLL3.7-pre-miR-29b和pLL3.7慢病毒;使用荧光定量RT-PCR检测发现,pLL3.7-pre-miR-29b感染能显著性降低BVDV拷贝数;与pLL3.7-pre-miR-29b感染的处理组相比较,pLL3.7感染的对照组中各组织病变情况较为严重。结果表明,BALB/c小鼠体内过表达miR-29b能明显抑制BVDV的复制,减轻BVDV感染造成的病变,为以后研发抗BVDV的有效策略和方法提供了理论依据。  相似文献   

8.
为建立H5N1亚型禽流感病毒感染海兰白鸡模型,本研究选取1株鹅源H5N1高致病性禽流感病毒A/goose/guangdong/1/96(H5N1)(简称GD1/96),测定其对4周龄海兰白鸡的半数致死量.感染模型试验中,将30只4周龄海兰白鸡随机分成3组,每组10只,5只直接感染,5只同居,试验组设置一个重复,将病毒液稀释至104.5EID50,滴鼻、点眼各0.1 mL,对照组接种PBS,感染后24 h放入同居鸡;感染后连续观察14 d,记录死亡时间,每天采集咽喉拭子和泄殖腔拭子;感染组和同居组第3、5 天各剖解3只鸡,采集气管、肺脏、脑、脾脏、肾脏和十二指肠,进行病毒分离;qRT-PCR法分析感染组和同居组第3、5 天鸡肺组织中IFN-α和TNF-α的相对表达量.结果显示,GD1/96株的鸡胚半数感染量(EID50)为10-8.167/0.1 mL,对4周龄海兰白鸡的半数致死量为104.5 EID50.感染模型试验结果显示,以104.5EID50的攻毒剂量感染海兰白鸡,感染组鸡在感染后8 d全部死亡;在感染和同居3 d后,各组鸡的咽喉拭子和泄殖腔拭子均可检测到病毒;感染和同居后第3、5 天,各组鸡的6种组织中均可分离到高滴度的病毒;IFN-α和TNF-α在感染组和同居组的鸡肺脏组织中的表达量均显著增加(P <0.05).本试验建立了海兰白鸡的H5N1亚型禽流感病毒感染模型,为H5N1亚型禽流感病毒的致病机理及表达抗流感基因转基因鸡的研究奠定了基础.  相似文献   

9.
试验旨在对猪乙型脑炎病毒(JEV,SA14-14-2株)在传代细胞上的繁殖培养特性及其制备的灭活疫苗免疫原性进行研究,确定猪JEV在细胞培养瓶中培养的关键技术参数及其灭活疫苗的免疫原性。以Vero细胞培养病毒,通过接种时间、接毒量、吸附时间、吸附温度、维持液pH、维持培养温度及培养时间7个条件的优化,将繁殖的病毒液冻融一次,采用病毒蚀斑数测定方法测定病毒滴度。按照优化好的条件繁殖一批毒液,经β-丙内酯灭活,与双相佐剂混合,制备成猪乙型脑炎灭活疫苗。两次免疫(间隔14 d)接种乙型脑炎抗体阴性仔猪,首次免疫前(0 d)、免疫后第7、14、21、28、35、42天采集血清,检测血清中和抗体。二免后第28天进行乙型脑炎P3强毒的攻击,攻毒前(0 d)、攻毒后第1、2、3、5、7、9天采集血浆,攻毒后第14天剖杀免疫猪,采集脑组织,检测血浆和脑组织中JEV。结果显示,用细胞培养瓶进行培养,将Vero细胞培养至48 h进行病毒接种,接种量为1 000 PFU/mL,病毒吸附温度为37℃,吸附时间为90 min,吸附后用pH 7.6~8.8维持液继续培养,培养温度为35℃,培养96 h后收获毒液,冻融一次,可获得较高滴度的病毒。仔猪免疫制备的灭活疫苗后血清抗体水平迅速升高,血浆和脑组织中均未检测出JEV,免疫组试验猪能抵抗强毒攻击,可获得有效免疫保护。本试验结果为猪乙型脑炎疫苗的生产提供了参考依据。  相似文献   

10.
犬瘟热病毒DNA疫苗接种犬的免疫保护   总被引:2,自引:0,他引:2  
用犬瘟热病毒(CDV)囊膜糖蛋白基因(H、F)和核蛋白基因(N)重组质粒DNA和聚乙烯胺(PEI)混合后肌注10只3月龄CDV抗体阴性毕格犬,间隔30 d,共免疫3次,另选择5只犬作为阴性对照.免疫3次后,采用CDV攻毒.对照组呈现出犬瘟热的典型症状和组织病理损害,攻毒3周内,有2只犬衰竭死亡,1只犬症状明显,攻毒第18天外周血淋巴细胞中病毒RNA检测为阳性.DNA疫苗免疫组除出现一过性的体温升高外,未出现明显症状,攻毒后第18天外周血淋巴细胞CDV检测仍为阴性.DNA疫苗免疫后血清ELlSA抗体和病毒中和抗体测定显示,首免后机体激发的ELISA抗体滴度很低(101.25±0.615),二免后开始缓慢升高(101.69±0.285),再次免疫后达到102.051±0.214;中和抗体也呈现以上规律,三免后血清中和抗体为101.75±0.190,攻毒后血清ELISA抗体和中和抗体滴度迅速升高(103.02±0.202和102.41±0.245).试验表明CDV基因免疫对CDV的感染具有较好的保护作用,并能清除进入机体内的病毒.CDV基因免疫只激发较低水平的体液免疫,中和抗体在攻毒前达不到临界保护线(102),但对CDV攻击能产生较好的保护,推测其免疫效力可能源于细胞免疫和记忆性B淋巴细胞.  相似文献   

11.
【Objective】 This study was aimed to verify whether the NP protein of Bovine parainfluenza virus type 3 (BPIV3) could enhance the immune effect of BPIV3 inactivated vaccine【Method】 The antigenicity of the protein encoded by NP gene was analyzed by bioinformatics softwares,and the antigenic region was screened.The truncated NP gene sequence of BPIV3 was amplified by PCR and connected to pET-32a(+) plasmid.Then the high-purity BPIV3 NP protein was obtained by E.coli prokaryotic expression system and Ni affinity chromatography.It was confirmed by Western blotting.BPIV3 was inactivated with 0.3% formaldehyde and mixed with Freund's adjuvant 1:1 to prepare inactivated vaccine.Eight New Zealand White rabbits were randomly divided into four groups with two rabbits in each group,including inactivated vaccine group,NP protein group,inactivated vaccine and NP protein mixed group and control group.Blood samples were collected before and every 7 days after immunization.The levels of specific antibodies and neutralizing antibodies in New Zealand White rabbits of the four groups were measured and compared by indirect ELISA and virus neutralization test.【Result】 DNAStar analysis showed that the average antigen index of amino acid region 193-368 of NP protein was 0.4-1.7,and the hydrophilic index was 0-1.5,which proved that this region had strong antigenicity and hydrophilicity.The NP gene was amplified by PCR and the recombinant expression vector was constructed.Gene sequencing showed that the recombinant expression vector was consistent with the expected results.The results of SDS-PAGE showed that NP protein was highly expressed with a molecular weight of 50 ku and expressed in the form of inclusion body.Western blotting showed that the expressed protein had strong reactivity.The results of ELISA showed that 28 days after immunization,the specific antibody titer of the control group was 0,and the specific antibody titers of inactivated vaccine group,NP protein group and inactivated vaccine and NP protein mixed group reached 1:211,1:217 and 1:218,respectively.The results of virus neutralization test showed that 28 days after immunization,the neutralizing antibody titer of the control group was 0,and the neutralizing antibody titers of inactivated vaccine group,NP protein group and inactivated vaccine and NP protein mixed group were 1:23.32,1:24.48 and 1:24.98,respectively.【Conclusion】 BPIV3 NP protein could enhance the immune effect of BPIV3 inactivated vaccine.Adding NP protein to the inactivated vaccine could be used as a new vaccination method of BPIV3 inactivated vaccine.  相似文献   

12.
Sixteen 8- to 9-week-old Pasteurella multocida-free New Zealand White rabbits were divided into two equal groups. The first group was inoculated intranasally with P multocida serotype D:1 strain and the second group that was inoculated with phosphate-buffered saline (PBS) only was used as a control group. Pasteurella multocida was isolated from the nasal cavity of all infected rabbits in group 1 and from tracheal swabs of seven rabbits in this group. Four rabbits in group 1 died with clinical signs of septicaemia, two rabbits had mucopurulent nasal discharge and pneumonic lesions and the other two did not show any clinical signs or gross lesions. The ultrastructural changes detected were deciliation or clumping of cilia of ciliated epithelium, cellular swelling, vacuolation and sloughing. The subepithelial capillaries showed congestion, intravascular fibrin deposition, platelets aggregation and endothelial injury. Pasteurella multocida was observed attached to the injured endothelial cells. Heterophils, mast cells, vacuolated monocytes and macrophages infiltrated the lamina propria and between the degenerated epithelial cells.  相似文献   

13.
旨在利用悬浮培养CHO细胞表达系统制备牛病毒性腹泻病毒(bovine viral diarrhea virus,BVDV) E2蛋白,并鉴定纯化E2蛋白的免疫原性。本研究以BVDV-1 NADL株基因序列为基础,构建BVDV E2蛋白的重组真核表达质粒pcDNA3.1-BVDV-E2,转染经悬浮培养的CHO细胞进行分泌表达,收集细胞培养上清,进行亲和层析法纯化,SDS-PAGE电泳鉴定蛋白表达和纯化,Western blot鉴定与His抗体和BVDV阳性血清反应性,利用纯化蛋白免疫新西兰大白兔,用细胞间接免疫荧光(IFA)和ELISA鉴定E2蛋白的反应活性。纯化E2蛋白经BCA蛋白定量试剂盒检测后表达量高达1.228 mg·mL-1;Western blot结果显示,利用His抗体和BVDV阳性血清均可检测到目的蛋白的特异性条带;新西兰大白兔一免后第7天利用间接ELISA可检测到血清抗体阳性,并持续至免疫后第28天,血清抗体效价水平达到1∶1 024 000;IFA试验结果显示,该血清抗体可检测到BVDV感染MDBK细胞中E2蛋白的表达,进一步证实纯化的E2蛋白具有良好的免疫原性和特异性。本研究成功利用CHO悬浮培养真核表达系统制备了纯化的BVDV E2蛋白,该蛋白具有良好的免疫原性,为BVDV的诊断方法及其新型亚单位疫苗研制奠定了基础。  相似文献   

14.
Several tests for Bovine viral diarrhea virus (BVDV) were applied to samples collected monthly from December 20, 2005, through November 27, 2006 (day 0 to day 342) from 12 persistently infected (PI) cattle with BVDV subtypes found in US cattle: BVDV-1a, BVDV-1b, and BVDV-2a. The samples included clotted blood for serum, nasal swabs, and fresh and formalin-fixed ear notches. The tests were as follows: titration of infectious virus in serum and nasal swabs; antigen-capture (AC) enzyme-linked immunosorbent assay (ELISA), or ACE, on serum, nasal swabs, and fresh ear notches; gel-based polymerase chain reaction (PCR) testing of serum, nasal swabs, and fresh ear notches; immunohistochemical (IHC) testing of formalin-fixed ear notches; and serologic testing for BVDV antibodies in serum. Of the 12 animals starting the study, 3 died with mucosal disease. The ACE and IHC tests on ear notches had positive results throughout the study, as did the ACE and PCR tests on serum. There was detectable virus in nasal swabs from all the cattle throughout the study except for a few samples that were toxic to cell cultures. The serum had a virus titer ≥ log10 1.60 in all samples from all the cattle except for 3 collections from 1 animal. Although there were several equivocal results, the PCR test most often had positive results. The BVDV antibodies were due to vaccination or exposure to heterologous strains and did not appear to interfere with any BVDV test. These findings illustrate that PI cattle may be identified by several tests, but differentiation of PI cattle from cattle with acute BVDV infection requires additional testing, especially of blood samples and nasal swabs positive on initial testing. Also, calves PI with BVDV are continual shedders of infectious virus, as shown by the infectivity of nasal swabs over the 11-mo study.  相似文献   

15.
本研究旨在建立水貂生长激素(mink growth hormone,mGH)的原核高效表达体系,探索mGH蛋白规模化生产方法,利用获得的目的蛋白制备特异抗血清。将已构建的原核表达载体pET28b-mGH转化大肠杆菌Rosetta(DE3)TM pLysS感受态细胞,经IPTG诱导表达,超声破碎菌体后离心获得包涵体蛋白,利用8 mol/L尿素对其进行溶解和复性,经Ni-NTA树脂亲和层析纯化获得重组蛋白。通过Western blotting检测及MALDI-TOF-MS质谱分析对获得的蛋白进行鉴定。用SDS-PAGE电泳法检测蛋白纯度,用BCA法测定其浓度。复性mGH蛋白与完全弗氏佐剂或不完全弗氏佐剂乳化制备免疫抗原,采用皮下多点注射法免疫3只新西兰大白兔,首次免疫剂量为600 μg/只,二免剂量为600 μg/只,三免剂量为400 μg/只。三免10 d后分离制备血清,Western blotting法检测其特异性,间接ELISA法检测其效价。结果表明,原核表达的包涵体经Ni-NTA柱纯化后所得蛋白鉴定为mGH融合蛋白;SDS-PAGE电泳鉴定复性mGH蛋白条带单一,纯度达90%以上,BCA法计算蛋白浓度为669 μg/mL,均达到了免疫动物的要求;制备的抗血清经Western blotting检测具有良好的结合特异性,间接ELISA法测定其抗体效价达1:256 000以上。上述结果表明,原核表达载体pET28b-mGH可在大肠杆菌Rosetta(DE3)TM pLysS细胞中高效表达mGH融合蛋白,表达蛋白经变性、复性和纯化后免疫新西兰大白兔,可制备高效价特异性抗血清。  相似文献   

16.
【目的】 探究由霍乱弧菌菌影(Vibrio cholerae ghosts,VCG)和纳米壳聚糖凝胶(Gel)组合制作的一种新型灭活衣原体疫苗复合佐剂是否可增强鹦鹉热衣原体原体(elementary body,EB)灭活抗原诱导动物机体产生的免疫应答。【方法】 将60只7日龄SPF鸡随机分为4个组,分别为:EB+VCG+Gel组、EB+VCG 组、Gel组和EB组。通过滴鼻途径免疫鸡群,免疫2次,每次间隔14 d,免疫后检测鸡血清中IgG抗体水平、淋巴细胞增殖指数、CD4/CD8T 细胞比例、细胞因子(白介素-4(IL-4)、IL-10、IL-12和干扰素-γ(IFN-γ))含量及攻毒后鸡喉头排菌量和肺脏的病理损伤程度。【结果】 与Gel和EB组相比,EB+VCG+Gel和EB+VCG组IgG 抗体水平、淋巴细胞增殖指数、IFN-γ含量和CD4/CD8T细胞比值显著或极显著升高(P<0.05;P<0.01)。此外,与Gel和EB组相比,攻毒后第12天,EB+VCG+Gel组喉头排菌量极显著降低(P<0.01),攻毒后第7天,肺脏损伤评分极显著降低(P<0.01)。【结论】 壳聚糖凝胶、VCG、灭活衣原体 EB 组合构成的新型滴鼻衣原体疫苗经鼻腔接种动物后可刺激动物机体产生良好的体液免疫和细胞免疫应答,阻断鹦鹉热衣原体经呼吸道途径传播,防止鹦鹉热衣原体从动物向人群传播。  相似文献   

17.
Bovine viral diarrhoea virus (BVDV) is an important pathogen of cattle that can naturally infect a wide range of even-toed ungulates. Non-bovine hosts may represent reservoirs for the virus that have the potential to hamper BVDV eradication programs usually focused on cattle. Rabbits are very abundant in countries such as the United Kingdom or Australia and are often living on or near livestock pastures. Earlier reports indicated that rabbits can propagate BVDV upon intravenous exposure and that natural infection of rabbits with BVDV may occur but experimental proof of infection of rabbits by a natural route is lacking. Therefore, New Zealand White rabbits were exposed to a Scottish BVDV field strain intravenously, oro-nasally and by contaminating their hay with virus. None of the animals showed any clinical signs. However, the lymphoid organs from animals sacrificed at day five after exposure showed histological changes typical of transient infection with pestivirus. Most organ samples and some buffy coat samples were virus positive at day five but saliva samples remained negative. Development of antibodies was observed in all intravenously challenged animals, in all of the nebulised group and in four of six animals exposed to contaminated hay. To our knowledge this is the first report of BVDV propagation in a species other than ruminants or pigs after exposure to the virus by a natural route. However, to assess the role of rabbits as a potential reservoir for BVDV it remains to be determined whether persistent infection caused by intra-uterine infection is possible and whether BVDV is circulating in wild rabbit populations.  相似文献   

18.
【目的】应用大肠杆菌表达系统表达牛病毒性腹泻病毒(BVDV) E0蛋白,纯化后免疫小鼠制备E0蛋白多克隆抗体用于BVDV的检测技术研究。【方法】采用PCR扩增BVDV的E0基因,将其连接至pET-28a (+)构建重组表达载体pET28a-E0。将重组质粒转化大肠杆菌BL21感受态细胞,经IPTG诱导、亲和层析纯化后,通过SDS-PAGE和Western blotting鉴定E0蛋白的表达情况。将纯化的E0蛋白免疫小鼠制备BVDV E0多克隆抗体,并通过Western blotting、细胞免疫荧光试验、ELISA等试验检测该多克隆抗体的特异性和效价,以及在BVDV检测中的应用。【结果】成功构建原核表达载体pET28a-E0,表达并纯化E0蛋白,制备的BVDV E0多克隆抗体可特异性识别纯化的E0蛋白及pET28a-E0在BL21中表达的总蛋白。进一步Western blotting、细胞免疫荧光试验、双抗夹心法ELISA证明制备的E0多克隆抗体可用于BVDV的检测。间接ELISA结果表明,E0多克隆抗体效价高于1∶64 000。【结论】制备的BVDV E0多克隆抗体效价高、抗原结合特异性强,为BVDV E0蛋白的生物学功能研究及BVDV的检测提供了材料支持。  相似文献   

19.
【目的】通过比较饲喂苜蓿鲜草和全价颗粒饲料对兔胃黏膜抗氧化能力和胃肌层结构的影响,为兔健康饲养和提高养殖户的收益提供依据。【方法】选用20只健康、体重相近的断奶新西兰兔,随机分为饲料组和苜蓿草组,每组10只,分别饲喂苜蓿鲜草和全价颗粒饲料,饲养30 d。通过空气栓塞法将新西兰兔处死后解剖,称量胃的长度和重量,利用生物化学法测定胃黏膜的抗氧化能力,包括总超氧化物歧化酶(T-SOD)、谷胱甘肽过氧化物酶(GSH-Px)活性和脂质过氧化物(LPO)、丙二醛(MDA)含量,胃pH以及胃蛋白酶的活性,同时运用组织切片技术、苏木精伊红染色及图像分析法测定胃的贲门部、胃底部、胃体部以及幽门部的肌层厚度。【结果】饲料组体重和胃液pH均显著高于苜蓿草组(P<0.05),而苜蓿草组胃相对重量、胃蛋白酶浓度以及胃黏膜抗氧化能力均显著或极显著高于饲料组(P<0.05;P<0.01)。苜蓿草组兔胃贲门部、胃底部以及幽门部的总肌层厚度均极显著大于饲料组(P<0.01),在贲门部苜蓿草组的纵行肌厚度显著大于饲料组(P<0.05),环行肌厚度极显著大于饲料组(P<0.01),在胃底部苜蓿草组斜行肌厚度显著大于饲料组(P<0.05),而其余部位的肌层厚度均无显著差异(P>0.05)。【结论】不同饲喂条件下,苜蓿草组胃化学消化能力、抗氧化能力以及胃肌层厚度均显著高于饲料组。  相似文献   

20.
本试验旨在研究饲粮中添加不同水平桑叶粉对新西兰白兔免疫与抗氧化功能及肌肉风味的影响。选用120只35日龄断奶的新西兰白兔,随机分为4组,每组3个重复,每个重复10只(公母各占1/2)。4组试验兔分别饲喂桑叶粉添加水平为0(对照组)、15%(试验Ⅰ组)、20%(试验Ⅱ组)、25%(试验Ⅲ组)的试验饲粮,试验期为35 d。结果显示:试验Ⅰ组和试验Ⅱ组血清酸性磷酸酶(ACP)活性和白细胞介素-6(IL-6)含量均显著高于对照组(P0.05)。随着桑叶粉添加水平的增加,血清溶菌酶(LZM)活性呈上升趋势,且试验Ⅱ组和试验Ⅲ组与对照组差异显著(P0.05)。试验I组血清过氧化氢酶(CAT)活性极显著高于对照组和试验Ⅲ组(P0.01)。血清丙二醛(M DA)含量在各试验组间无显著差异(P0.05),但各试验组均显著低于对照组(P0.05)。随着桑叶粉添加水平的增加,血清总抗氧化能力(T-AOC)呈现上升趋势,且各试验组均显著高于对照组(P0.05)。试验Ⅰ组和试验Ⅱ组背最长肌中肌苷酸含量均显著高于对照组(P0.05)。试验Ⅱ组和试验Ⅲ组腿肌中肌苷酸含量均显著高于对照组(P0.05)。试验Ⅰ组与试验Ⅱ组背最长肌和腿肌中必需氨基酸、鲜味氨基酸、总氨基酸以及多不饱和脂肪酸含量均高于对照组(P0.05)。由此得出,桑叶粉在改善新西兰白兔免疫与抗氧化功能及肌肉风味方面有很好的效果,并且以15%~20%添加水平效果较佳。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号